vs
Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $5.5M, roughly 1.1× Taysha Gene Therapies, Inc.). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -507.8%, a 488.4% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 45.9%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -12.7%).
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
CVR vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.0M | $5.5M |
| Net Profit | $-1.2M | $-27.9M |
| Gross Margin | 2.7% | — |
| Operating Margin | -15.3% | -516.0% |
| Net Margin | -19.3% | -507.8% |
| Revenue YoY | 45.9% | 171.3% |
| Net Profit YoY | 68.0% | -48.3% |
| EPS (diluted) | — | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.0M | $5.5M | ||
| Q3 25 | $7.4M | $0 | ||
| Q2 25 | $7.3M | $2.0M | ||
| Q1 25 | $7.2M | $2.3M | ||
| Q4 24 | $4.1M | $2.0M | ||
| Q3 24 | $7.0M | $1.8M | ||
| Q2 24 | $8.1M | $1.1M | ||
| Q1 24 | $7.9M | $3.4M |
| Q4 25 | $-1.2M | $-27.9M | ||
| Q3 25 | $67.6K | $-32.7M | ||
| Q2 25 | $-395.0K | $-26.9M | ||
| Q1 25 | $401.0K | $-21.5M | ||
| Q4 24 | $-3.6M | $-18.8M | ||
| Q3 24 | $-1.4M | $-25.5M | ||
| Q2 24 | $142.1K | $-20.9M | ||
| Q1 24 | $-698.0K | $-24.1M |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 22.9% | — | ||
| Q4 24 | -43.7% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 17.6% | — | ||
| Q1 24 | 9.5% | — |
| Q4 25 | -15.3% | -516.0% | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | -5.7% | -1347.1% | ||
| Q1 25 | 1.0% | -930.5% | ||
| Q4 24 | -86.4% | -985.8% | ||
| Q3 24 | -11.8% | -1448.4% | ||
| Q2 24 | 1.3% | -1915.4% | ||
| Q1 24 | -11.5% | -713.3% |
| Q4 25 | -19.3% | -507.8% | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | -5.4% | -1353.6% | ||
| Q1 25 | 5.5% | -935.2% | ||
| Q4 24 | -88.0% | -929.0% | ||
| Q3 24 | -20.8% | -1427.5% | ||
| Q2 24 | 1.8% | -1882.0% | ||
| Q1 24 | -8.9% | -705.4% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.8M | $246.9M |
| Total Assets | $23.3M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $319.8M | ||
| Q3 25 | $1.7M | $297.3M | ||
| Q2 25 | $1.2M | $312.8M | ||
| Q1 25 | $765.6K | $116.6M | ||
| Q4 24 | $2.2M | $139.0M | ||
| Q3 24 | $2.2M | $157.7M | ||
| Q2 24 | $2.6M | $172.7M | ||
| Q1 24 | $2.7M | $124.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.8M | $246.9M | ||
| Q3 25 | $20.0M | $219.0M | ||
| Q2 25 | $20.0M | $248.7M | ||
| Q1 25 | $20.4M | $55.1M | ||
| Q4 24 | $20.0M | $71.5M | ||
| Q3 24 | $23.7M | $88.8M | ||
| Q2 24 | $25.2M | $108.9M | ||
| Q1 24 | $25.2M | $53.8M |
| Q4 25 | $23.3M | $343.3M | ||
| Q3 25 | $24.0M | $316.6M | ||
| Q2 25 | $23.6M | $333.3M | ||
| Q1 25 | $24.1M | $138.4M | ||
| Q4 24 | $23.4M | $160.4M | ||
| Q3 24 | $26.4M | $180.2M | ||
| Q2 24 | $27.3M | $200.4M | ||
| Q1 24 | $27.8M | $153.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $116.4K | $-26.7M |
| Free Cash FlowOCF − Capex | $24.3K | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.4K | $-26.7M | ||
| Q3 25 | $638.0K | $-24.2M | ||
| Q2 25 | $28.2K | $-20.2M | ||
| Q1 25 | $-2.0M | $-22.0M | ||
| Q4 24 | $-60.1K | $-18.3M | ||
| Q3 24 | $-58.2K | $-21.6M | ||
| Q2 24 | $363.5K | $-21.5M | ||
| Q1 24 | $-398.8K | $-19.8M |
| Q4 25 | $24.3K | — | ||
| Q3 25 | $492.1K | $-24.3M | ||
| Q2 25 | $-22.8K | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-118.1K | $-18.3M | ||
| Q3 24 | $-368.9K | $-21.6M | ||
| Q2 24 | $58.0K | $-21.7M | ||
| Q1 24 | $-491.8K | $-19.9M |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | -28.3% | — | ||
| Q4 24 | -2.9% | -905.5% | ||
| Q3 24 | -5.3% | -1210.9% | ||
| Q2 24 | 0.7% | -1951.9% | ||
| Q1 24 | -6.3% | -584.5% |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 4.5% | 2.0% | ||
| Q2 24 | 3.8% | 18.1% | ||
| Q1 24 | 1.2% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
TSHA
Segment breakdown not available.
